Edition:
United States

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

2.34USD
26 May 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.34
Open
$2.32
Day's High
$2.35
Day's Low
$2.26
Volume
181,816
Avg. Vol
288,702
52-wk High
$65.70
52-wk Low
$2.26

OPHT.OQ

Chart for OPHT.OQ

About

Ophthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $83.90
Shares Outstanding(Mil.): 35.85
Dividend: --
Yield (%): --

Financials

  OPHT.OQ Industry Sector
P/E (TTM): -- 137.90 17.41
EPS (TTM): -5.62 -- --
ROI: -71.56 -8.48 -5.42
ROE: -- -11.31 -4.68

BRIEF-David Shaw reports a 5 pct passive stake in Ophthotech Corp as of May 11, 2017

* David Shaw reports a 5.0 percent passive stake in Ophthotech Corp as of May 11, 2017 - SEC filing Source text for Eikon: Further company coverage:

May 22 2017

BRIEF-Ophthotech reports Q1 loss per share $1.20

* Ophthotech reports first quarter 2017 financial and operating results

May 03 2017

BRIEF-Ophthotech says Glenn Sblendorio to become chief executive officer

* Says David Carroll promoted to chief financial officer, effective immediately

Apr 24 2017

BRIEF-Morgan Stanley reports 6.1 pct passive stake in Ophthotech- SEC Filing

* Morgan Stanley reports 6.1 percent passive stake in Ophthotech Corp, as of March 2, 2017 - SEC filing Source text for Eikon: Further company coverage:

Mar 08 2017

BRIEF-Ophthotech reports Q4 loss per share $1.86

* Ophthotech reports fourth quarter and full year 2016 financial and operating results

Feb 28 2017

BRIEF-Ophthotech names Keith Westby COO

* Ophthotech Corp says Glenn P. Sblendorio assumes position of president and Keith Westby takes on role of chief operating officer

Feb 01 2017

BRIEF-Ophthotech on Dec. 16, 2016 announced reduction in personnel is expected to involve about 80 pct of workforce

* Ophthotech -on dec 16, 2016, co announced that it had determined to implement a reduction in personnel to focus on an updated business plan

Jan 17 2017

BRIEF-Ophthotech says provided written notice to Ajinimoto Althea Inc terminating capacity reservation agreement - SEC filing

* Ophthotech - on January 5, co provided written notice to Ajinimoto Althea Inc terminating capacity reservation agreement - SEC filing

Jan 06 2017

More From Around the Web

Competitors

Earnings vs. Estimates